Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


FDA: Zofran 32-mg Dose Pulled From Market
The anti-nausea drug may cause serious heart problems at that dosage
This article is older than one year and is no longer available.

Copyright © 2012 HealthDay. All rights reserved.

March 5, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

FDA: Opdivo Approval Expanded to Include Lung Cancer

Major Health, Cost Burden for U.S. Patients With Eczema

Rush University Adds Patient Scores to Doctor Profiles

Correlated Spectroscopy IDs Changes in BRCA1/2 Carriers

CDC: Heroin Overdose Mortality Nearly Tripled 2010 to 2013

Resistance to Common Antimicrobials Increasing